Skip to content

Role of Preoperative Serum Thyroglobulin Level to Differentiate Between Different Thyroid Nodules

Role of Preoperative Serum Thyroglobulin Level to Differentiate Between Different Thyroid Nodules

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06157632
Enrollment
30
Registered
2023-12-06
Start date
2023-12-20
Completion date
2024-11-25
Last updated
2023-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Level of Thyrogobulin in Different Thyroid Nodules

Brief summary

Role of preoperative serum thyroglobulin level to differentiate between different thyroid nodules

Detailed description

Incidence of thyroid nodules varies according to the methods of diagnosis, 4-7% by palpation and 17-67% by high resolution ultrasound. The gold standard of diagnosis for thyroid nodules is fine needle aspiration (FNA); however, fine needle aspiration cytology (FNAC) alone is insufficient to detect cancer because of inadequate cytology (5-15%) and in cases of follicular neoplasm (15-25%) where only surgery is diagnostically conclusive. Therefore, other factors in addition to FNA should be considered to predict malignancy. This study is done to evaluate the association between elevated pre-operative thyroglobulin levels and histopathologically proven thyroid carcinoma. Metabolism of thyroglobulin occurs in the liver and via thyroid gland and recycling of the protein takes place. Circulating thyroglobulin features a half lifetime of 65 hours. Following thyroidectomy, it will take many weeks before thyroglobulin levels become undetectable. After thyroglobulin levels become undetectable (following thyroidectomy), levels are often serially monitored. A subsequent elevation of the thyroglobulin level is an indicator of recurrence of papillary or follicular thyroid carcinoma. Hence, thyroglobulin levels in the blood are mainly used as a tumor marker for certain kinds of thyroid cancer (particularly papillary or follicular thyroid cancer). Thyroglobulin is not produced by medullary or anaplastic carcinoma. Therefore, this study tries to evaluate the association between the preoperative thyroglobulin levels and thyroid carcinoma proven by post-operative histopathology.

Interventions

PROCEDUREThyriodectomy

Thyroidectomy

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

patients with thyoid nodules that will do thyriodectomy

Eligibility

Sex/Gender
ALL
Age
15 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. age between 15 to 70 years old 2. patients with solitary thyroid nodules 3. pateints who are fit for surgeries

Exclusion criteria

* 1\_patients who are unfit for surgeries 2\_ age below 15 years and above 70 years old 3-patients with thyroid nodule receiving drugs that affect thyroglobulin level as iodine

Design outcomes

Primary

MeasureTime frameDescription
Role of preoperative serum thyroglobulin level to differentiate between different thyroid nodulesTwo yearUse of serum thyroglobulin to differentiate between different thyroid nodules preoperoperatively

Contacts

Primary ContactAhmed Gamal, Master
Gamal8431@gmail.com01062142009
Backup ContactMohamed Hasan, Prof
mh.osman@yahoo.com0 122 3971586

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026